A Trial of Metformin in Individuals With Fragile X Syndrome

Clinical trial NCT03479476 · COMPLETED

Trial details

NCT number: NCT03479476
Sponsor: University of California, Davis
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Fragile X Syndrome Fragile X Mental Retardation Syndrome Mental Retardation, X Linked Genetic Diseases, X-Linked Trinucleotide Repeat Expansion Fra(X) Syndrome Intellectual Disability FXS Neurobehavioral Manifestations Sex Chromosome Disorders

Start date: 2018-04-30
Primary completion: 2024-05-22
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.